In the samples taken after neoadjuvant treatment, however, a significant decrease was observed in SPOCK1 expression in tumor cells, with a mean immune score of 1.3 (p < 0.001) (Figure 8c, Table S2). This evidence concerns the gene SPOCK1 and neoplasm.